Navigation Links
Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
Date:2/28/2008

MONTVALE, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today reported net earnings of $128.4 million, or $1.18 per share, for the year ended December 31, 2007 on revenues of $2.5 billion. On a non-GAAP basis, adjusted earnings per share were $3.16 for 2007. A reconciliation of GAAP-based earnings per share to adjusted earnings per share is presented in the table at the end of this press release. For the fourth quarter ended December 31, 2007, net earnings were $32.5 million, or $0.30 per share, on revenues of $668.7 million. On a non-GAAP basis, adjusted earnings per share were $0.79 for the quarter.

In the fourth quarter of calendar 2006, Barr changed its fiscal year end from June 30th to December 31st, effective December 31, 2006. In addition, on October 24, 2006, Barr acquired PLIVA d.d., a Croatian generics pharmaceutical company, for approximately $2.4 billion. As a result of these two events, the comparison of information for the year ended December 31, 2007 and the 12- month period ended December 31, 2006, which is unaudited, is not very meaningful. In this release, "2007" refers to Barr's calendar year ended December 31, 2007, and "2006" refers to the 12-month period ended December 31, 2006 and includes PLIVA's results from October 25, 2006 through December 31, 2006.

"I am pleased to report strong revenue growth across the Company in 2007, driven by proprietary and U.S. generic sales, as well as sound results in our international markets. In addition, during the year we invested a record $248 million in new product development, and filed a record 30 ANDAs and three NDAs in the United States. These are exceptional results for our Company, particularly given that significant management
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... of patented university inventions licensed to biotechnology firms ... commercialization. To open these roadblocks, the researchers suggest ... the discovery stage could lead to faster commercialization ... derived from discoveries made in university laboratories and ... during clinical trials, which have a high failure ...
(Date:8/20/2014)... , Aug. 20, 2014  Decision Resources Group finds that the ... Russia , India and ... in 2013, roughly equal to the size of the ... BRIC market will experience much faster growth as a result of ... Other key findings from Decision Resources Group,s coverage of ...
(Date:8/20/2014)... nerves in your ear could improve the health of ... the University of Leeds used a standard TENS machine ... electrical pulses to the tragus, the small raised flap ... of the ear canal. , The stimulation changed the ... reducing the nervous signals that can drive failing hearts ...
(Date:8/19/2014)... 2014 Research and Markets  has announced the addition ... Business Report" report to their offering. This ... in US$ Thousands by the following Product Segments: Media, Sera, and ... US, Canada , Japan , ... Latin America . Annual estimates and forecasts are ...
Breaking Biology Technology:Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3'Tickling' your ear could be good for your heart 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2
... ConBio Lasers to be Exclusively Featured in Leading Dental Education ... ... 12 HOYA ConBio(TM), a global,leader in dental and aesthetic ... internationally recognized dental education,company, in which VersaWave(TM) and DioDent(TM) Micro ...
... Mersana, a cancer,therapeutics company, announced today that Timothy ... Officer., "We are thrilled that Tim is now ... President and CEO at Mersana. "His extensive leadership in,oncology ... an,ideal match for Mersana. In addition to the important ...
... CuraGen Corporation,(Nasdaq: CRGN ) announced today that ... present at the BIO CEO & Investor Conference,on Wednesday, ... Access to a live webcast of the presentation ... the webcast will be accessible,beginning one hour after the ...
Cached Biology Technology:HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 2HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 3Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D. 2
(Date:8/20/2014)... melanomas the rare type of skin cancer that caused ... other more common types of skin cancer, according to a ... Cell & Melanoma Research . , Acral melanoma most often ... nail-beds and other hairless parts of the skin. Unlike other ... damage from the sun. , The team, from the Cancer ...
(Date:8/20/2014)... synthetic rugs and plastic bags could one day be ... than petroleum, scientists are now reporting. The novel process ... world deal with its agricultural and plastic waste problems, ... Athanassia Athanassiou, Ilker S. Bayer and colleagues at the ... is constantly growing. In 2012, its production reached 288 ...
(Date:8/20/2014)... and its energy is finally utilized for the ... mostly build from silicon based semiconductors, also harness ... the development of cheaper and renewable photovoltaics consists ... protein complexes of photosynthesis. Prof. Dr. Matthias Rgner,s ... cyanobacteria that live in a hot spring in ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2A semi-artificial leaf faster than 'natural' photosynthesis 2
... from King,s College London have identified patterns of epigenetic ... genetically identical twins who differ in autism traits. The ... largest of its kind and may shed light on ... activity of certain genes and in turn contribute to ...
... , April 22, 2013 The U.S. Farmers  & ... from multiple disciplines, including farmers, media, industry and academia,  ... This discussion was moderated by CNBC Senior Analyst and ... Chicago , which took place during ...
... WHAT: ... Charitable Trusts as the "Biomedical Researcher of the Month," for his ... As a postdoctoral researcher in the Princeton University laboratory of Lynn ... type 1 (HSV-1)which, in rare cases, can lead to blindness or ...
Cached Biology News:Epigenetic changes shed light on biological mechanism of autism 2Epigenetic changes shed light on biological mechanism of autism 3CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago 2CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago 3Viral curiosity spreads across continents 2
... is making flow cytometry accessible to anyone in ... the latest addition to Guavas on-demand microcapillary flow ... easy to use, surprisingly affordable, very compact, and ... detection. The Guava EasyCyte Mini has all of ...
... to hold up to 6 strain chambers with ... to use design ensures that cells grow over ... or compression. This unit allows you to control ... produce 64 unique strain settings. The instrument fits ...
... unique combination of Coulter volume and ... and accurate cell counting. This flow ... UV, allowing flexible fluorochrome selection for ... only achievable with larger, more expensive ...
... The Cytomics FC 500 Series ... equipped with the most advanced ... Series delivers flexible testing, powerful ... features that help researchers optimize ...
Biology Products: